Trial intelligence / Profile preview

Lupeol for Mild-moderate Acne

NCT02152865Completed

Sponsor
Seoul National University Hospital
Start
Dec 2009
Primary completion
May 2014
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Randomised trial in acne vulgaris comparing Lupeol Side with Vehicle Side (2 arms). Primary endpoint: Acne lesion counts at 8 weeks. Started Dec 2009; status: completed.

02

Drugs

Lupeol
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT02152865.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02152865.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call